BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8648681)

  • 1. Repression of the alpha0 gene by ICP4 during a productive herpes simplex virus infection.
    Lium EK; Panagiotidis CA; Wen X; Silverstein S
    J Virol; 1996 Jun; 70(6):3488-96. PubMed ID: 8648681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of the herpes simplex virus 1 alpha 4 gene by its gene product (ICP4) within the context of the viral genome is conditioned by the distance and stereoaxial alignment of the ICP4 DNA binding site relative to the TATA box.
    Leopardi R; Michael N; Roizman B
    J Virol; 1995 May; 69(5):3042-8. PubMed ID: 7707531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between TATA-binding protein and herpes simplex virus type 1 ICP4 DNA-binding sites in complex formation and repression of transcription.
    Kuddus R; Gu B; DeLuca NA
    J Virol; 1995 Sep; 69(9):5568-75. PubMed ID: 7637002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A virus with a mutation in the ICP4-binding site in the L/ST promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading frame P, exhibits cell-type-specific expression of gamma(1)34.5 transcripts and latency-associated transcripts.
    Lee LY; Schaffer PA
    J Virol; 1998 May; 72(5):4250-64. PubMed ID: 9557715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection.
    Rivera-Gonzalez R; Imbalzano AN; Gu B; Deluca NA
    Virology; 1994 Aug; 202(2):550-64. PubMed ID: 8030221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitution of a TATA box from a herpes simplex virus late gene in the viral thymidine kinase promoter alters ICP4 inducibility but not temporal expression.
    Imbalzano AN; DeLuca NA
    J Virol; 1992 Sep; 66(9):5453-63. PubMed ID: 1323706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transactivation of Herpes Simplex Virus 1 (HSV-1) Infected Cell Protein 4 Enhancer by Glucocorticoid Receptor and Stress-Induced Transcription Factors Requires Overlapping Krüppel-Like Transcription Factor 4/Sp1 Binding Sites.
    Ostler JB; Thunuguntla P; Hendrickson BY; Jones C
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33208447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4.
    Gu B; DeLuca N
    J Virol; 1994 Dec; 68(12):7953-65. PubMed ID: 7966586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilized binding of TBP to the TATA box of herpes simplex virus type 1 early (tk) and late (gC) promoters by TFIIA and ICP4.
    Zabierowski SE; Deluca NA
    J Virol; 2008 Apr; 82(7):3546-54. PubMed ID: 18216093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of ICP4, TATA-binding protein, and RNA polymerase II to herpes simplex virus type 1 immediate-early, early, and late promoters in virus-infected cells.
    Sampath P; Deluca NA
    J Virol; 2008 Mar; 82(5):2339-49. PubMed ID: 18094162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4.
    Samaniego LA; Webb AL; DeLuca NA
    J Virol; 1995 Sep; 69(9):5705-15. PubMed ID: 7637016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus infected cell polypeptide 4 preferentially represses Sp1-activated over basal transcription from its own promoter.
    Gu B; Rivera-Gonzalez R; Smith CA; DeLuca NA
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9528-32. PubMed ID: 8415735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus transactivator ICP4 operationally substitutes for the cellular transcription factor Sp1 for efficient expression of the viral thymidine kinase gene.
    Imbalzano AN; Coen DM; DeLuca NA
    J Virol; 1991 Feb; 65(2):565-74. PubMed ID: 1846184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a promoter-specific transactivation domain in the herpes simplex virus regulatory protein ICP4.
    Xiao W; Pizer LI; Wilcox KW
    J Virol; 1997 Mar; 71(3):1757-65. PubMed ID: 9032304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of activator-mediated transcription by herpes simplex virus ICP4 via a mechanism involving interactions with the basal transcription factors TATA-binding protein and TFIIB.
    Gu B; Kuddus R; DeLuca NA
    Mol Cell Biol; 1995 Jul; 15(7):3618-26. PubMed ID: 7791769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding sites for the herpes simplex virus immediate-early protein ICP4 impose an increased dependence on viral DNA replication on simple model promoters located in the viral genome.
    Koop KE; Duncan J; Smiley JR
    J Virol; 1993 Dec; 67(12):7254-63. PubMed ID: 8230448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.
    Goins WF; Sternberg LR; Croen KD; Krause PR; Hendricks RL; Fink DJ; Straus SE; Levine M; Glorioso JC
    J Virol; 1994 Apr; 68(4):2239-52. PubMed ID: 8139009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RR1 gene of herpes simplex virus type 1 is uniquely trans activated by ICP0 during infection.
    Desai P; Ramakrishnan R; Lin ZW; Osak B; Glorioso JC; Levine M
    J Virol; 1993 Oct; 67(10):6125-35. PubMed ID: 8396674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB.
    Smith CA; Bates P; Rivera-Gonzalez R; Gu B; DeLuca NA
    J Virol; 1993 Aug; 67(8):4676-87. PubMed ID: 8392607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The initiator element in a herpes simplex virus type 1 late-gene promoter enhances activation by ICP4, resulting in abundant late-gene expression.
    Kim DB; Zabierowski S; DeLuca NA
    J Virol; 2002 Feb; 76(4):1548-58. PubMed ID: 11799149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.